Stay updated on Pembrolizumab Combos in mCRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.

Latest updates to the Pembrolizumab Combos in mCRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn NIH-wide notice about a terminology transition appears at the top of the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content and blocking access to the NCT03374254 details.SummaryDifference23%

- Check47 days agoChange DetectedThe study page now shows a newer revision tag (v3.7.0), indicating the page was updated to the latest version.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check82 days agoChange DetectedUpdated the page revision label from v3.6.4 to v3.6.5 to reflect a new build; this is a small, informational update with no changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combos in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combos in mCRC Clinical Trial page.